5-chloromethylfluorescein diacetate has been researched along with pemetrexed in 1 studies
Studies (5-chloromethylfluorescein diacetate) | Trials (5-chloromethylfluorescein diacetate) | Recent Studies (post-2010) (5-chloromethylfluorescein diacetate) | Studies (pemetrexed) | Trials (pemetrexed) | Recent Studies (post-2010) (pemetrexed) |
---|---|---|---|---|---|
107 | 0 | 38 | 2,469 | 657 | 1,695 |
Protein | Taxonomy | 5-chloromethylfluorescein diacetate (IC50) | pemetrexed (IC50) |
---|---|---|---|
Thymidylate synthase | Escherichia coli | 1.1 | |
Dihydrofolate reductase | Homo sapiens (human) | 4.0309 | |
Dihydrofolate reductase | Lacticaseibacillus casei | 2.3 | |
Thymidylate synthase | Homo sapiens (human) | 8.1787 | |
Dihydrofolate reductase | Escherichia coli K-12 | 2.3 | |
Folate receptor beta | Homo sapiens (human) | 0.2585 | |
Folate receptor alpha | Homo sapiens (human) | 0.2417 | |
Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | 0.0342 | |
Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | 0.07 | |
Reduced folate transporter | Homo sapiens (human) | 0.0928 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 1.655 | |
Proton-coupled folate transporter | Homo sapiens (human) | 0.0229 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, V; Dantzig, AH; Perry, WI; Pratt, S; Starling, JJ | 1 |
1 other study(ies) available for 5-chloromethylfluorescein diacetate and pemetrexed
Article | Year |
---|---|
Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antimetabolites, Antineoplastic; Cyclic Nucleotide Phosphodiesterases, Type 5; Fluoresceins; Fluorescent Dyes; Glutamates; Guanine; HeLa Cells; Humans; Kinetics; Membrane Transport Proteins; Methotrexate; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Pemetrexed; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Probenecid; Propionates; Quinolines; Reproducibility of Results; Staining and Labeling; Transfection | 2006 |